Atlas Trials

Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT01373229 · COMPLETED

Trial details

NCT number
NCT01373229
Sponsor
David Rizzieri, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Leukemia, Lymphocytic, Chronic, B-Cell
Start date
2012-01-01
Primary completion
2014-03-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.